These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12399143)

  • 1. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa.
    Frank GK; Kaye WH; Meltzer CC; Price JC; Greer P; McConaha C; Skovira K
    Biol Psychiatry; 2002 Nov; 52(9):896-906. PubMed ID: 12399143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Mathis CA; Wagner A; Thornton L; Hoge J; Ziolko SK; Becker CR; McConaha CW; Kaye WH
    Biol Psychiatry; 2007 May; 61(9):1090-9. PubMed ID: 17241616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.
    Kaye WH; Frank GK; Meltzer CC; Price JC; McConaha CW; Crossan PJ; Klump KL; Rhodes L
    Am J Psychiatry; 2001 Jul; 158(7):1152-5. PubMed ID: 11431241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
    Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
    Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
    Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.
    Savic I; Lindström P; Gulyás B; Halldin C; Andrée B; Farde L
    Neurology; 2004 Apr; 62(8):1343-51. PubMed ID: 15111672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter binding after recovery from eating disorders.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Becker C; Ziolko SK; Mathis CA; Wagner A; Barbarich-Marsteller NC; Putnam K; Kaye WH
    Psychopharmacology (Berl); 2007 Dec; 195(3):315-24. PubMed ID: 17690869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
    Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
    Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
    Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
    Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
    Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
    Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
    Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
    Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
    van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
    Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.